COVID-19 and IBD

COVID-19 Virus

Dear Patients, Caregivers and Friends, 

Our hearts and thoughts go out to everyone affected by this unprecedented event. We know this is a challenging time for everyone and we are working hard to provide information that helps you and your loved ones navigate through this situation. 

The novel coronavirus (COVID-19) has raised many questions from people affected by Crohn’s or colitis. Like all of you, we are watching, monitoring and assessing the global impact of COVID-19. The decisions we make are taken very seriously and factor in information from the Public Health Agency of Canada (PHAC) and our Scientific Medical Advisory Council (SMAC). 

The health and safety of the Crohn’s and Colitis Canada community and your loved ones is our highest priority and we will do our very best to support you through this evolving situation. 

As such, we are making available new tools that provide expert IBD guidance:

  • An IBD & COVID-19 section developed by IBD experts on our website; and
  • A webinar series beginning March 19 to provide up-to-date information and answer questions. The first webinar will be held on Thursday March 19 at 7 PM (EST)

As an added precaution, we are refraining from hosting any in-person events in the next 60 days. Please check our website regularly for the latest updates on COVID-19 and events in your community. 

As always, if you are uncertain about how to proceed, please consult your healthcare provider.

If you have any questions or concerns, or if there is any other way that we can support you, please do not hesitate to contact us at and we will respond as soon as we can.

Sending our love and best wishes to our IBD family in Canada and across the globe.

Warm regards,

Mina Mawani
President & CEO

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.

Other Areas of Interest